Subscribe
shutterstock_1569668848_sundry_photography
Sundry Photography / Shutterstock.com
16 December 2019AmericasRory O'Neill

Senators demand USPTO probe into Gilead allegations

The US Patent and Trademark Office (USPTO) is coming under increasing pressure to review allegations that Gilead delayed development of its latest HIV drug in order to maximise profits.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Sanders calls on USPTO to block Gilead patent extension
9 December 2019   US presidential candidate Bernie Sanders has called on the US Patent and Trademark Office to block extensions to two Gilead Sciences patents covering HIV prevention drugs including Descovy.


Editor's picks

A step too far? Why Stewart’s approach is dividing opinion
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

Editor's picks

Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025

More on this story

Americas
Sanders calls on USPTO to block Gilead patent extension
9 December 2019   US presidential candidate Bernie Sanders has called on the US Patent and Trademark Office to block extensions to two Gilead Sciences patents covering HIV prevention drugs including Descovy.

More on this story

Americas
Sanders calls on USPTO to block Gilead patent extension
9 December 2019   US presidential candidate Bernie Sanders has called on the US Patent and Trademark Office to block extensions to two Gilead Sciences patents covering HIV prevention drugs including Descovy.

More features

Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?
Broad Institute wins appeal to restore CRISPR patent in Europe
BMS faces fresh lawsuit over alleged cancer drug monopoly
WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations
Boies Schiller Flexner adds three-strong litigation team